gastrointestin
diseas
human
immunodefici
viru
hiv
span
entir
gi
tract
mouth
rectum
spectrum
gastrointestin
symptom
hiv
rang
odynophagia
dysphagia
nausea
vomit
abdomin
pain
fi
nalli
diarrhea
tenesmu
normal
host
gastrointestin
disord
common
hiv
patient
whether
opportunist
infect
secondari
patient
immunosuppress
statu
medic
induc
etiolog
almost
hiv
aid
patient
gastrointestin
complaint
throughout
cours
ill
dramat
chang
hiv
care
highli
activ
antiretrovir
therapi
art
incid
opportunist
infect
decreas
result
clinic
pictur
gastrointestin
ill
hiv
chang
evalu
hiv
patient
gastrointestin
complaint
requir
thorough
histori
physic
exam
addit
select
studi
order
diagnos
correct
diseas
treat
accordingli
patient
hiv
aid
typic
upper
gastrointestin
symptom
rang
dysphagia
diffi
culti
swallow
odynophagia
feel
pain
upon
swallow
least
onethird
patient
hiv
art
era
esophag
complaint
incid
increas
progress
diseas
symptom
patient
secondari
opportunist
infect
caus
patient
immunosuppress
state
relat
degre
immunosuppress
common
etiolog
esophag
patholog
esophag
aid
patient
tabl
candida
speci
herp
simplex
viru
hsv
cytomegaloviru
cmv
addit
also
entiti
idiopath
esophag
ulcer
ieu
also
seen
hiv
patient
may
immunolog
mediat
caus
hiv
etiolog
esophag
complaint
includ
malign
especi
lymphoma
kaposi
sarcoma
noninfecti
caus
howev
introduct
proteas
inhibitor
pi
art
decreas
incid
aid
esophag
complaint
hiv
day
relat
common
etiolog
like
gastroesophag
refl
ux
diseas
gerd
opportunist
infect
addit
common
symptom
dysphagia
odynophagia
symptom
also
suggest
esophag
diseas
hiv
patient
like
chest
pain
nausea
vomit
anorexia
weight
loss
symptom
acut
chronic
progress
cours
addit
dysphagia
often
associ
candid
esophag
wherea
odynophagia
gener
symptomat
esophag
ulcer
diseas
patient
dysphagia
odynophagia
also
may
one
ill
concurr
imper
pursu
thorough
investig
etiolog
esophag
complaint
hiv
patient
evalu
hiv
patient
esophag
symptom
defi
nitiv
need
includ
endoscopi
biopsi
gold
standard
allow
physician
visual
esophag
lumen
biopsi
affect
site
fig
histori
physic
exam
obvious
import
may
lead
discoveri
gerd
pillinduc
esophag
addit
patient
dissemin
cmv
eg
cmv
retin
esophag
symptom
especi
odynophagia
may
respond
cmv
antivir
therapi
absenc
diagnost
endoscopi
biopsi
common
sign
physic
exam
relat
esophag
complaint
oral
thrush
suggest
esophag
candidiasi
patient
esophag
complaint
patient
especi
dysphagia
dysphagia
odynophagia
sole
odynophagia
may
benefi
cial
document
respons
empir
trial
oral
fl
uconazol
oppos
endoscopi
symptomat
respons
fl
uconazol
presum
patient
candid
esophag
proceed
accordingli
addit
histori
physic
exam
way
evalu
esophag
complaint
barium
esophagographi
rel
insensit
nonspecifi
c
use
diagnost
purpos
characterist
fi
nding
candid
esophag
diffus
mucos
irregular
result
shaggi
appear
mimick
diffus
ulcer
cmv
ieu
may
appear
well
circumscrib
ulcer
may
shallow
deep
indistinguish
barium
swallow
cours
radiographi
determin
neoplast
origin
dysphagia
patient
malign
anoth
form
evalu
brush
cytolog
cytolog
brush
pass
nasogastr
tube
obtain
tissu
viral
cultur
immunohistochemistri
unfortun
lead
larg
sampl
error
done
blindli
without
visual
lumen
miss
diagnos
patient
may
two
infecti
process
ieu
diagnos
viral
cultur
cytolog
brush
add
littl
evalu
aid
patient
esophag
endoscopi
biopsi
endoscopi
biopsi
gener
yield
viral
fungal
diagnosi
base
cultur
hematoxylin
eosin
stain
exclud
viral
etiolog
sever
biopsi
sampl
show
etiolog
ulcer
tent
exclusionari
diagnosi
ieu
made
candid
esophag
common
caus
esophag
hiv
patient
especi
patient
complaint
dysphagia
odynophagia
dysphagia
fungal
isol
gener
candida
albican
though
speci
candida
also
affect
esophagu
suspect
patient
lymphocyt
count
cellsmm
though
occur
count
esophag
symptom
without
thrush
absent
patient
patient
hiv
new
onset
symptom
empir
trial
standard
dose
fl
uconazol
effect
strategi
patient
prospect
studi
respond
respons
endoscopi
pursu
patient
fail
empir
antifung
therapi
common
etiolog
patient
ulcer
esophag
oppos
persist
candidiasi
fluconazol
drug
choic
candidiasi
load
dose
mg
oral
follow
mg
daili
day
clotrimazol
troch
also
success
topic
treatment
esophag
candidiasi
nystatin
itraconazol
ketoconazol
effi
caciou
system
therapi
effect
fl
uconazol
amphotericin
b
also
help
therapi
gener
use
azoleresist
patient
toxic
medic
lowdos
amphotericin
mgkg
per
day
day
usual
adequ
caspofungin
also
use
candid
esophag
felt
effi
caciou
fl
uconazol
well
toler
howev
avail
intraven
form
expens
may
drug
choic
azoleresist
mucos
candidiasi
rel
lack
toxic
compar
amphotericin
b
primari
prophylaxi
candid
diseas
recommend
nonlifethreaten
natur
diseas
effect
acut
therapi
risk
antifung
resist
candida
common
esophag
pathogen
also
occur
addit
ulcer
esophag
hiv
patient
cmv
esophag
common
etiolog
odynophagia
hiv
patient
therefor
esophag
ulcer
patient
one
prospect
studi
fever
substern
chest
pain
report
addit
odynophagia
thrush
concomit
dysphagia
uncommon
diagnosi
cmv
best
made
endoscopi
biopsi
patholog
show
viral
cytopath
effect
gastrointestin
mucosa
via
intranuclear
inclus
immunohistochemistri
also
help
confi
rmation
viral
cultur
less
sensit
specifi
c
cmv
common
viral
pathogen
esophagu
hiv
patient
esophag
common
extraocular
manifest
cmv
appear
diffus
esophag
singl
multipl
ulcer
giant
ulcer
involv
whole
esophagu
gener
occur
lymphocyt
count
may
discov
treatment
candida
may
exist
concurr
patient
incid
cmv
esophag
declin
dramat
art
era
treatment
cmv
esophag
involv
wide
array
antivir
medic
name
ganciclovir
valganciclovir
foscarnet
cidofovir
ganciclovir
fi
rst
agent
use
combat
cmv
data
behind
respons
rate
given
intraven
week
induct
period
mgkg
per
day
dose
limit
sideeffect
mainli
bone
marrow
suppress
result
neutropenia
thrombocytopenia
oral
ganciclovir
also
use
mainten
therapi
data
limit
intraven
foscarnet
mgkg
bid
week
seen
equal
effect
intraven
ganciclovir
treatment
cmv
esophag
come
nephrotox
sideeffect
profi
le
howev
random
studi
shown
equal
effi
caci
safeti
foscarnet
gener
use
case
clinic
failur
ganciclovir
induct
oral
valganciclovir
mg
day
test
cmv
esophag
bioavail
intraven
ganciclovir
cidofovir
also
treat
cmv
typic
use
nephrotox
hsv
esophag
rel
uncommon
caus
esophag
ulcer
hiv
patient
compar
cmv
ieu
endoscop
appear
describ
well
circumscrib
volcano
like
appear
distinguish
ulcer
seen
cmv
infect
tend
linear
longitudin
deeper
treatment
oral
acyclovir
mgkg
per
day
though
patient
diffi
culti
swallow
intraven
acyclovir
use
valacyclovir
famciclovir
also
use
effi
caci
conveni
dose
schedul
foscarnet
intraven
mgkg
bid
use
case
acyclovir
resist
secondari
prophylaxi
valacyclovir
mgday
recommend
patient
frequent
relaps
idiopath
esophag
ulcer
ieu
diagnosi
exclus
none
patholog
fungal
viral
studi
return
diagnosi
treatment
idiopath
esophag
ulcer
done
oral
corticosteroid
gener
start
mg
oral
prednison
daili
patient
take
medic
oral
corticosteroid
given
intraven
addit
thalidomid
also
use
ieu
corticosteroid
effi
caciou
addit
infect
ulcer
discuss
esophag
issu
hiv
name
motil
neuropath
issu
form
hiv
neuropathi
could
lead
gastrointestin
complaint
like
gastroparesi
would
treat
symptomat
prokinet
agent
like
metoclopramid
addit
patient
symptomat
esophag
complaint
well
asymptomat
fi
nding
esophag
motil
abnorm
probabl
neurotrop
natur
hiv
lead
autonom
dysfunct
gastrointestin
neurolog
plexu
problem
associ
stomach
hiv
patient
similar
stomach
problem
nonhiv
infect
individu
opportunist
infect
affect
hiv
patient
typic
affect
stomach
symptom
present
often
relat
abdomin
pain
nausea
vomit
common
manifest
gastric
ill
hiv
patient
like
gener
popul
name
gerd
peptic
ulcer
diseas
pud
gastriti
care
need
use
prescrib
h
blocker
protonpump
inhibitor
ppi
howev
medic
interact
art
especi
ppi
workup
gener
popul
endoscopi
biopsi
gold
standard
diagnosi
helicobact
pylori
common
caus
peptic
ulcer
diseas
nonhiv
posit
patient
seem
decreas
incid
hiv
patient
compar
gener
popul
cmv
may
actual
lead
caus
pud
hiv
patient
far
actual
hivrel
gastric
patholog
gastric
lymphoma
kaposi
sarcoma
opportunist
organ
eg
cmv
tuberculosi
toxoplasmosi
cryptococcosi
seen
addit
dyspepsia
nausea
vomit
relat
sideeffect
variou
antiretrovir
medic
one
common
complaint
hiv
patient
diarrhea
reason
diarrhea
multifold
commonli
relat
opportunist
infect
antiretrovir
medic
depth
coverag
diarrheal
ill
hiv
patient
discuss
later
ch
etiolog
manag
diarrhea
hivinfect
patient
impact
antiretrovir
therapi
overview
follow
esophag
diseas
incid
opportunist
infect
decreas
art
era
though
incid
chronic
diarrhea
remain
steadi
even
art
era
evalu
diarrhea
includ
thorough
histori
physic
much
determin
elicit
patient
histori
symptom
diarrhea
occur
upper
abdomin
cramp
bloat
suggest
upper
intestin
sourc
enter
bloodi
diarrhea
tenesmu
lower
abdomin
cramp
impli
colon
involv
addit
patient
histori
recept
anal
intercours
higher
involv
coliti
sexual
transmit
pathogen
eg
gonorrhea
hsv
etc
anorect
area
homosexu
bisexu
men
higher
incid
diarrhea
patient
risk
group
obvious
travel
diet
histori
also
import
histori
hiv
patient
diarrhea
aspect
hiv
opportunist
infect
tend
common
set
lower
lymphocyt
count
therefor
greater
immunosuppress
diagnost
studi
involv
workup
diarrhea
hiv
patient
similar
gener
popul
addit
histori
physic
exam
exam
specifi
calli
add
littl
diagnosi
evid
malnutrit
fi
rst
rout
investig
often
stool
examin
test
order
includ
bacteri
cultur
clostridium
diffi
cile
toxin
assay
well
look
ova
parasit
especi
isospora
cryptosporidium
microsporidia
gener
need
specifi
ed
potenti
pathogen
sampl
sent
microbiolog
look
ova
parasit
addit
gram
stain
methylen
blue
stain
fecal
leukocyt
also
help
evid
fecal
leukocyt
may
point
toward
pictur
coliti
anoth
form
noninvas
test
blood
cultur
serolog
help
diagnosi
system
opportunist
infect
like
mycobacterium
avium
intracellular
mai
viral
etiolog
like
cmv
especi
patient
diarrhea
fever
mai
may
possibl
howev
etiolog
diagnosi
may
treat
symptom
may
still
persist
secondari
infect
may
also
present
coliti
barium
enema
abdomin
radiographi
may
detail
presenc
toxic
megacolon
complic
clostridium
diffi
cile
coliti
addit
noninvas
studi
list
absenc
diagnosi
workup
diarrhea
includ
invas
studi
well
fi
rst
step
gener
fl
exibl
sigmoidoscopi
give
visual
colon
diagnos
rule
pseudomembran
coliti
among
etiolog
provid
tissu
biopsi
abnorm
tissu
biopsi
mucosa
normal
random
tissu
sent
fl
exibl
sigmoidoscopi
better
altern
requir
sedat
small
intestin
etiolog
suspect
egd
go
past
second
portion
duodenum
help
determin
caus
diarrhea
biopsi
small
bowel
sent
patholog
also
electron
microscopi
cultur
analysi
fl
exibl
sigmoidoscopi
nondiagnost
still
diagnosi
studi
colonoscopi
perform
biopsi
done
rule
opportunist
infect
especi
ileum
rare
done
howev
gener
absenc
defi
nitiv
diagnosi
lead
treatment
evalu
discuss
later
symptom
associ
enter
typic
associ
diarrhea
prolong
malabsorpt
lead
malnutrit
gener
opportunist
infect
similar
patholog
hiv
patient
incid
enter
decreas
highli
activ
antiretrovir
therapi
art
era
main
symptom
enter
copiou
volumin
diarrhea
lday
dehydr
malabsorpt
oppos
coliti
bloodi
pain
diarrhea
workup
enter
detail
specifi
calli
includ
stool
studi
nondiagnost
esophagogastroduodenoscopi
egd
biopsi
etiolog
enter
hiv
patient
multifold
includ
bacteri
viral
infect
small
intestin
enter
fungal
parasit
pathogen
diagnos
stool
studi
detail
earlier
parasit
may
common
etiolog
enter
especi
patient
art
greatli
immunosuppress
parasit
typic
diagnos
stool
analysi
ova
parasit
includ
direct
fl
uoresc
antibodi
dfa
enzymelink
immunosorb
assay
elisa
polymeras
chain
reaction
pcr
light
microscopi
use
though
pcr
diagnost
much
lower
level
parasit
infect
cryptosporidium
parvum
commonli
identifi
abl
pathogen
aid
relat
persist
diarrhea
especi
patient
lymphocyt
count
typic
treat
paromomycin
mg
everi
h
oral
azithromycin
mg
four
time
day
though
albendazol
mg
twice
day
also
shown
effect
nitazoxanid
g
twice
daili
least
week
also
use
treatment
cryptosporidiosi
cure
gener
possibl
lymphocyt
count
howev
studi
children
show
benefi
nitazoxanid
hiv
children
hiv
seroneg
one
hyperimmun
bovin
colostrum
also
use
typic
cure
parasit
infect
microsporidiosi
next
commonli
identifi
abl
refractori
diarrhea
hiv
patient
treat
albendazol
well
mg
everi
h
oral
case
poorli
respons
treatment
requir
indefi
nite
therapi
isospora
belli
rare
usa
common
develop
countri
trimethoprimsulfamethoxazol
one
doubl
strength
tablet
everi
h
day
treatment
choic
pyrimethamin
mg
four
time
daili
folin
acid
mg
oral
four
time
daili
accept
patient
allergi
sulfa
medic
lastli
giardia
lamblia
amoeb
dysenteri
also
occur
hiv
patient
incid
gener
popul
treat
metronidazol
mg
thrice
daili
day
tinidazol
g
oral
giardiasi
day
ameb
dysenteri
strongyloidosi
thiabendazol
mgkg
twice
daili
oral
drug
choic
albendazol
seem
activ
parasit
organ
associ
diarrhea
hiv
patient
could
fi
rst
line
therapi
parasit
infect
suspect
pend
microbiolog
studi
aforement
parasit
treatment
target
pathogen
also
diarrheal
symptom
use
somatostatin
analog
like
octreotid
tri
reduc
amount
diarrhea
addit
sinc
parasit
common
chronic
lower
lymphocyt
count
art
reduc
degre
immunosuppress
also
cur
opioid
tinctur
opium
codein
provid
symptomat
relief
case
sever
diarrhea
constip
action
well
pain
relief
bulk
agent
lactosefre
diet
antidiarrh
medic
like
diphenoxyl
atropin
loperamid
also
benefi
cial
treat
diarrheal
symptom
viral
infect
hiv
patient
caus
diarrhea
typic
coliti
also
rare
enter
cmv
addit
caus
esophag
also
affect
gi
tract
diarrheal
ill
run
spectrum
asymptomat
carriag
sever
diarrheal
ill
includ
append
bleed
perfor
typic
occur
set
sever
immunosuppress
lymphocyt
count
diagnosi
cmv
enterocol
best
made
demonstr
viral
cytopath
effect
tissu
specimen
viral
stool
cultur
also
signifi
diseas
though
less
sensit
treatment
cmv
enterocol
mainli
ganciclovir
foscarnet
describ
earlier
esophag
section
valganciclovir
may
achiev
adequ
bioavail
enterocol
virus
affect
hiv
patient
gastrointestin
tract
includ
rotaviru
adenoviru
norwalk
viru
unusu
picornavirus
coronavirus
tend
less
common
patholog
previous
describ
diffi
cult
diagnos
well
adenoviru
caus
hemorrhag
coliti
acut
diarrhea
seen
patient
adenoviru
stool
patient
adenoviru
biopsi
specimen
gener
chronic
diarrhea
hsv
caus
diarrhea
via
system
infect
endstag
hiv
patient
caus
coliti
proctiti
hiv
mucos
lesion
hsv
treat
acyclovir
valacyclovir
famciclovir
acyclovir
resist
foscarnet
previous
describ
esophag
section
addit
hiv
may
caus
hiv
enteropathi
diarrheal
pathogen
may
identifi
ed
gut
tissu
patient
controversi
idiopath
aid
enteropathi
hand
term
use
chronic
diarrhea
aid
patient
without
identifi
abl
pathogen
diagnosi
despit
intens
investig
mucos
hyperprolifer
note
biopsi
etiolog
addit
art
increas
lymphocyt
count
reduc
immunosuppress
treat
symptomat
bulk
agent
antidiarrh
opioid
combin
antidiarrh
therapi
art
shown
benefi
cial
antidiarrh
therapi
alon
hiv
patient
chronic
diarrhea
agent
caus
enter
includ
mycobacterium
avium
intracellular
mai
pneumocysti
jiroveci
pcp
small
intestin
diseas
common
site
gastrointestin
lumin
involv
mai
often
seen
diffus
small
bowel
infi
ltration
mimick
whippl
diseas
caus
sever
malabsorpt
patient
lymphocyt
count
malabsorpt
diarrhea
occur
fever
night
sweat
addit
weight
loss
mai
must
consid
blood
cultur
bone
marrow
biopsi
may
diagnost
dissemin
mai
infect
diagnos
mai
enter
diffi
cult
howev
posit
stool
diagnost
gastrointestin
diseas
though
suggest
subsequ
dissemin
diseas
endoscop
biopsi
acidfast
stain
show
acidfast
bacilli
give
ideal
diagnosi
treatment
multitud
option
use
combin
clarithromycin
mg
twice
daili
ethambutol
mg
oral
daili
azithromycin
mg
daili
rifampin
mg
daili
rifabutin
mg
daili
amikacin
mgkg
three
time
weekli
ciprofl
oxacin
mg
twice
daili
reduc
erad
mai
lumin
tuberculosi
also
occur
exampl
extrapulmonari
involv
rare
contrast
mai
gener
treat
cure
antitubercul
therapi
pneumocysti
jiroveci
pcp
also
seen
caus
diarrhea
hiv
patient
uncommon
especi
set
pcp
prophylaxi
aid
patient
treatment
antipneumocysti
therapi
gener
trimethoprimsulfamethoxazol
bacteri
infect
hiv
patient
typic
caus
pictur
coliti
instead
enter
bloodi
diarrhea
tenesmu
common
bacteri
pathogen
seen
hiv
patient
includ
salmonella
shigella
e
coli
campylobact
jejuni
clostridium
diffi
cile
salmonellosi
time
common
hiv
patient
immunocompet
host
recurr
salmonella
bacteremia
establish
diagnosi
aid
hiv
patient
diagnosi
straightforward
salmonella
normal
cultur
stool
specimen
addit
blood
cultur
result
salmonella
gastroenter
present
either
wateri
diarrhea
dysenteri
mucopurul
diarrhea
without
fever
abdomin
pain
nausea
vomit
though
diarrhea
may
selflimit
treatment
gener
ciprofl
oxacin
mg
oral
twice
day
week
erad
shigella
similar
present
salmonellosi
similar
wide
spectrum
present
ill
come
high
rate
sever
complic
includ
anemia
hypoglycemia
sepsi
hemolyt
urem
syndrom
dissemin
intravascular
coagulopathi
renal
failur
mortal
obvious
increas
also
treat
ciprofl
oxacin
mg
twice
day
oral
day
diagnos
stool
cultur
well
campylobact
jejuni
gener
present
wateri
diarrhea
incid
probabl
decreas
due
widespread
pcp
prophylaxi
trimethoprimsulfamethoxazol
typic
harder
cultur
stool
may
diagnos
endoscop
biopsi
antimicrobi
therapi
essenti
though
erythromycin
mg
oral
four
time
daili
ciprofl
oxacin
mg
oral
twice
day
day
may
reduc
durat
ill
e
coli
may
seen
sever
strain
like
enter
bacteri
diarrheal
ill
treat
fl
uoroquinolon
like
ciprofl
oxacin
illustr
case
suspect
bacteri
diarrhea
ciprofl
oxacin
would
cover
enter
pathogen
would
empir
drug
choic
clostridium
diffi
cile
seen
hiv
patient
presenc
antibiot
therapi
also
absenc
recent
antibiot
therapi
common
antibiot
caus
c
diffi
cile
clindamycin
ampicillin
cephalosporin
aminoglycosid
clinic
present
respons
therapi
differ
hiv
patient
patient
without
hiv
diagnosi
made
detect
c
diffi
cile
toxin
stool
assay
treatment
metronidazol
mg
oral
everi
h
day
tinidazol
addit
stop
offend
initi
antibiot
therapi
resist
case
oral
vancomycin
mg
everi
h
use
rifaximin
mg
three
time
daili
though
effect
vancomycin
case
suspect
c
diffi
cile
without
diagnosi
via
stool
toxin
assay
fl
exibl
sigmoidoscopi
look
pseudomembran
coliti
diagnost
c
diffi
cile
fungal
etiolog
diarrhea
hiv
patient
rel
rare
occur
patient
immunocompromis
state
low
lymphocyt
count
gastrointestin
histoplasmosi
appear
commonli
describ
fungal
etiolog
diarrhea
hiv
patient
typic
occur
coliti
set
system
infect
diagnosi
made
fungal
cultur
smear
tissu
blood
treatment
amphotericin
b
mgkg
per
day
intraven
initi
mainten
therapi
itraconazol
mg
oral
daili
coccidiomycosi
cryptococcosi
also
rare
occur
presenc
system
infect
well
addit
candid
infect
common
opportunist
infect
hiv
patient
dehydr
diarrhea
also
occur
manifest
infect
obvious
caus
diarrhea
hiv
patient
secondari
opportunist
infect
sever
noninfecti
etiolog
diarrhea
hiv
patient
occur
well
includ
common
druginduc
diarrhea
common
drug
caus
diarrhea
hiv
patient
nucleosid
revers
transcriptas
inhibitor
nrti
proteas
inhibitor
pi
proteas
inhibitor
diarrhea
common
sideeffect
report
nelfi
navir
saquinavir
commonli
occur
initi
treatment
caus
cessat
therapi
lack
adher
treatment
newer
agent
like
lopinavirritonavir
seem
caus
less
diarrhea
older
pi
like
nelfi
navir
treatment
gener
guid
toward
treatment
symptom
name
bulk
agent
antidiarrh
like
loperamid
caus
diarrhea
hiv
patient
includ
infl
ammatori
bowel
diseas
includ
crohn
diseas
ulcer
coliti
neither
increas
incid
hiv
patient
treatment
tailor
accord
diseas
process
though
activ
diseas
process
may
decreas
lymphocyt
count
may
revers
colectomi
addit
aid
relat
ill
noninfecti
also
caus
diarrhea
gastrointestin
issu
includ
lymphoma
kaposi
sarcoma
diagnos
biopsi
infi
ltration
mucos
tract
neoplasm
lead
diarrhea
weight
loss
anorect
diseas
big
compon
hiv
gastrointestin
care
especi
among
homosexu
male
interestingli
incid
anorect
patholog
hiv
patient
affect
art
mani
anorect
patholog
seen
hiv
patient
includ
anal
fi
stula
fi
ssure
perirect
abscess
ulcer
proctiti
box
addit
anal
neoplasm
result
human
papillomaviru
hpv
etiolog
also
occur
anorect
carcinoma
increas
incid
hiv
patient
among
homosexu
male
fourth
common
malign
seen
hiv
hiv
homosexu
men
twice
incid
hiv
neg
homosexu
men
anal
squamou
cell
carcinoma
frequent
associ
squamou
intraepitheli
neoplasia
hpv
much
like
cervic
carcinoma
detect
anorect
cytolog
similar
papanicola
smear
gold
standard
diagnosi
anorect
neoplast
diseas
still
anoscopi
biopsi
though
anorect
cytolog
use
screen
test
addit
anal
carcinoma
anorect
symptom
common
hiv
popul
especi
among
homosexu
male
anal
condyloma
common
hiv
relat
anal
patholog
associ
hpv
infect
treatment
option
includ
varieti
surgic
option
includ
cryotherapi
four
common
infecti
caus
proctiti
men
sex
men
gonorrhea
herp
simplex
chlamydia
syphili
gonorrhea
chlamydia
typic
treat
togeth
ceftriaxon
mg
im
azithromycin
g
oral
fl
uoroquinolon
oral
cephalospo
rin
doxycyclin
mg
oral
twice
day
day
also
use
primari
syphili
treat
benzathin
penicillin
g
million
unit
im
doxycyclin
mg
twice
daili
week
penicillin
allerg
hsv
infect
describ
earlier
esophag
coliti
also
caus
perian
rectal
ulcer
associ
symptom
tenesmu
pain
bleed
treatment
antiherpet
medic
like
acyclovir
valacyclovir
famciclovir
explain
earlier
foscarnet
acyclovirresist
case
etiolog
proctiti
includ
lymphogranuloma
venereum
well
caus
coliti
detail
clinic
overlap
also
happen
hiv
patient
addit
thorough
physic
examin
patient
anorect
symptom
anoscopi
sigmoidoscopi
mucos
biopsi
look
fi
ssure
perirect
abscess
fi
stula
addit
search
opportunist
infect
microbiolog
studi
sent
viral
fungal
bacteri
cultur
